Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.

To determine whether GM1-like epitopes in Campylobacter species are specific to O serotypes associated with Guillain-Barré syndrome (GBS) or whether they are frequent among random Campylobacter isolates causing enteritis, 275 random enteritis-associated isolates of Campylobacter jejuni were analyzed. To determine whether GM1-like epitopes in Campylobacter species are specific to O serotypes associated with Guillan-Barre syndrome (GBS) or whether they are frequent among random Campylobacter isolates causing enteritis, 275 enteritis-associated isolates, randomly collected in the United States, were analyzed using a cholera-toxin binding assay [corrected]. Overall, 26.2% of the isolates were positive for the GM1-like epitope. Of the 36 different O serotypes in the sample, 21 (58.3%) contained no strains positive for GM1, whereas in 6 serotypes (16.7%), >50% of isolates were positive for GM1. GBS-associated serotypes were more likely to contain strains positive for GM1 than were non-GBS-associated serotypes (37.8% vs. 15.1%, P=.0116). The results suggest that humans are frequently exposed to strains exhibiting GM1-like mimicry and, while certain serotypes may be more likely to possess GM1-like epitopes, the presence of GM1-like epitopes on Campylobacter strains does not itself trigger GBS.

[1]  G. Mckhann,et al.  Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndrome , 1999, Annals of neurology.

[2]  A. Lastovica,et al.  Lipopolysaccharides from Campylobacter jejuni O:41 Strains Associated with Guillain-Barré Syndrome Exhibit Mimicry of GM1 Ganglioside , 1998, Infection and Immunity.

[3]  G. Mckhann,et al.  Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome , 1998, Neurology.

[4]  D. Sack,et al.  Microtiter Assay for DetectingCampylobacter spp. and Helicobacter pylori with Surface Gangliosides Which Bind Cholera Toxin , 1998, Journal of Clinical Microbiology.

[5]  H. Obayashi,et al.  Characterization of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome , 1997, Journal of the Neurological Sciences.

[6]  J. Penner,et al.  Diversity of lipopolysaccharide structures in Campylobacter jejuni. , 1997, The Journal of infectious diseases.

[7]  A. Lastovica,et al.  Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains. , 1997, The Journal of infectious diseases.

[8]  F. Vriesendorp,et al.  Insights into Campylobacter jejuni-induced Guillain-Barré syndrome from the Lewis rat model of experimental allergic neuritis. , 1997, The Journal of infectious diseases.

[9]  R. Hughes,et al.  Clinical and epidemiologic features of Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.

[10]  J. Buzby,et al.  The economic burden of Campylobacter-associated Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.

[11]  G. Mckhann,et al.  Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.

[12]  A. Moran,et al.  Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides. , 1997, The Journal of infectious diseases.

[13]  A. Moran,et al.  Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome , 1997, Infection and immunity.

[14]  E. Nielsen,et al.  Distribution of serotypes of Campylobacter jejuni and C. coli from Danish patients, poultry, cattle and swine. , 1997, FEMS immunology and medical microbiology.

[15]  K. Tadokoro,et al.  Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain‐Barré syndrome and Fisher's syndrome , 1997, Annals of neurology.

[16]  G. Sobue,et al.  Axonal pathology in Japanese Guillain-Barré syndrome: a study of 15 autopsied cases. , 1997, Neurology.

[17]  A. Lugaresi,et al.  Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1 a antibodies following Campylobacter enteritis , 1997, Journal of the Neurological Sciences.

[18]  R. Hughes,et al.  Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain–Barré syndrome (GBS) , 1997, Journal of Neuroimmunology.

[19]  B. Appelmelk,et al.  Review: Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: implications in pathogenesis , 1996 .

[20]  G. Mckhann,et al.  Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma , 1996, Annals of neurology.

[21]  C. Li,et al.  Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[22]  L. Mermel,et al.  Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3 , 1996, Infection and immunity.

[23]  I. Nachamkin,et al.  Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system , 1996, Journal of clinical microbiology.

[24]  A. Moran,et al.  Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome , 1995 .

[25]  R. Vaughan,et al.  HLA-class II alleles in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection , 1995, Journal of Neuroimmunology.

[26]  A. Moran,et al.  Potential role of lipopolysaccharides of Campylobacter jejuni in the development of Guillain-Barre syndrome , 1995 .

[27]  A. Moran,et al.  Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide. , 1995, European journal of biochemistry.

[28]  M. Blaser,et al.  Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. , 1995, Brain : a journal of neurology.

[29]  G. Mckhann,et al.  Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. , 1995, Brain : a journal of neurology.

[30]  T. Miyatake,et al.  Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome , 1994, Annals of neurology.

[31]  Taki,et al.  Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope , 1994, Infection and immunity.

[32]  A. McDonald,et al.  Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure , 1994, Infection and immunity.

[33]  A. McDonald,et al.  Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. , 1994, Biochemistry.

[34]  T. Miyatake,et al.  A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure , 1993, The Journal of experimental medicine.

[35]  M. Blaser,et al.  Serologic Evidence of Previous Campylobacter jejuni Infection in Patients with the Guillain-Barre Syndrome , 1993, Annals of Internal Medicine.

[36]  S. Ostroff,et al.  Common somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States , 1993, Journal of clinical microbiology.

[37]  A. McDonald,et al.  Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. , 1993, European journal of biochemistry.

[38]  A. McDonald,et al.  Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. , 1993, European journal of biochemistry.

[39]  M. Blaser,et al.  Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China , 1993, Annals of neurology.

[40]  T. Saida,et al.  Campylobacter jejuni strains from patients with guillain‐barré syndrome belong mostly to penner serogrpup 19 and contain β‐N‐acetylglucosamine residues , 1993 .

[41]  S. D. Mills,et al.  Antigenicity of Helicobacter pylori lipopolysaccharides , 1992, Journal of clinical microbiology.

[42]  B. Spangler,et al.  Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. , 1992, Microbiological reviews.

[43]  T. Miyatake,et al.  Severe acute axonal form of Guillain–Barré syndrome associated with IgG anti‐GD1a antibodies , 1992, Muscle & nerve.

[44]  M. Blaser,et al.  Campylobacter Jejuni: Current Status and Future Trends , 1992 .

[45]  E. Rietschel,et al.  Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose , 1991, Journal of bacteriology.

[46]  J. Kaldor,et al.  Guillain-Barré syndrome associated with Campylobacter infection. , 1985, Australian and New Zealand journal of medicine.

[47]  L. Kurland,et al.  An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. , 1984, American journal of epidemiology.

[48]  J. Penner,et al.  Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens , 1980, Journal of clinical microbiology.

[49]  M. Mumenthaler,et al.  The Landry-Guillain-Barré syndrome Complications, prognosis and natural history in 123 cases , 1977, Journal of the Neurological Sciences.

[50]  J. Mcleod,et al.  Acute idiopathic polyneuritis A clinical and electrophysiological follow-up study , 1976, Journal of the Neurological Sciences.

[51]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[52]  J. Prineas Acute idiopathic polyneuritis. An electron microscope study. , 1972, Laboratory investigation; a journal of technical methods and pathology.

[53]  R. Adams,et al.  THE INFLAMMATORY LESION IN IDIOPATHIC POLYNEURITIS , 1969 .

[54]  A. Sabin,et al.  Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome. , 1969, JAMA.

[55]  J. Gatenby,et al.  AN ELECTRON MICROSCOPE STUDY , 1957 .

[56]  W. Haymaker,et al.  THE LANDRY‐GUILLAIN-BARRÉ SYNDROME: A CLINICOPATHOLOGIC REPORT OF FIFTY FATAL CASES AND A CRITIQUE OF THE LITERATURE , 1949, Medicine.

[57]  Robert V. Tauxe,et al.  Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations , 2000 .

[58]  G. Mckhann,et al.  Human autoimmune neuropathies. , 1998, Annual review of neuroscience.

[59]  J W Griffin,et al.  Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome , 1996, Journal of neurocytology.

[60]  A. McDonald,et al.  Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. , 1994, Biochemistry.

[61]  黒木 茂一 Campylobacter jejuni strains from patiensts with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues , 1994 .